Literature DB >> 18219540

Comparison of enzymically glucuronidated flavonoids with flavonoid aglycones in an in vitro cellular model of oxidative stress protection.

David E Stevenson1, Janine M Cooney, Dwayne J Jensen, Reginald Wibisono, Aselle Adaim, Margot A Skinner, Jingli Zhang.   

Abstract

This study modeled, in vitro, the potential effect of conjugative (phase II) metabolism on the cytoprotective capacity of fruit flavonoids against oxidative stress. Flavonoid aglycones were compared with their corresponding isomeric mixtures of glucuronides for their ability to enhance the survival of cultured human Jurkat T and neuroblastoma cells stressed with hydrogen peroxide. Various polyphenolic compounds were tested as substrates in vitro for an ovine liver glucuronyl transferase preparation. Flavonoids and their glycoside derivatives were found to be good substrates, whereas phenolic acids were either poor or nonsubstrates. Five common flavonoids were glucuronidated to prepare mixtures for bioassay testing. Glucuronidation generally weakened the cytoprotective capacities of flavonoids (in the presence of H(2)O(2)), but some compounds were weakened much more than others. The concentration that halved cell death was well below 0.5 microM for most flavonoids tested, but glucuronidation increased median effective concentration values to a range of 1-16 microM. This compares with the generally accepted physiological range (0.1-10 microM) for circulating dietary polyphenolics detected in the body. Therefore, some flavonoids may retain a reduced cytoprotective capacity in vitro, after glucuronidation, whereas others may be effectively inactivated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219540     DOI: 10.1007/s11626-007-9072-y

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  35 in total

1.  Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry.

Authors:  J Wittig; M Herderich; E U Graefe; M Veit
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-04-05

2.  Cellular titration of apoptosis with steady state concentrations of H(2)O(2): submicromolar levels of H(2)O(2) induce apoptosis through Fenton chemistry independent of the cellular thiol state.

Authors:  F Antunes; E Cadenas
Journal:  Free Radic Biol Med       Date:  2001-05-01       Impact factor: 7.376

3.  In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway.

Authors:  Mònica Comalada; Desirée Camuesco; Saleta Sierra; Isabel Ballester; Jordi Xaus; Julio Gálvez; Antonio Zarzuelo
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

4.  Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin.

Authors:  A J Day; F Mellon; D Barron; G Sarrazin; M R Morgan; G Williamson
Journal:  Free Radic Res       Date:  2001-12

5.  Caspase-dependent and -independent events in apoptosis induced by hydrogen peroxide.

Authors:  D K Kim; E S Cho; H D Um
Journal:  Exp Cell Res       Date:  2000-05-25       Impact factor: 3.905

6.  Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.

Authors:  Marelle G Boersma; Hester van der Woude; Jan Bogaards; Sjef Boeren; Jacques Vervoort; Nicole H P Cnubben; Marlou L P S van Iersel; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

7.  Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin.

Authors:  Kerstin M Janisch; Gary Williamson; Paul Needs; Geoffrey W Plumb
Journal:  Free Radic Res       Date:  2004-08

8.  Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans.

Authors:  Kitti Németh; Geoff W Plumb; Jean-Guy Berrin; Nathalie Juge; Ralf Jacob; Hassan Y Naim; Gary Williamson; Dallas M Swallow; Paul A Kroon
Journal:  Eur J Nutr       Date:  2003-01       Impact factor: 5.614

9.  Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women.

Authors:  Pamela J Mink; Carolyn G Scrafford; Leila M Barraj; Lisa Harnack; Ching-Ping Hong; Jennifer A Nettleton; David R Jacobs
Journal:  Am J Clin Nutr       Date:  2007-03       Impact factor: 7.045

Review 10.  Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity.

Authors:  Jeremy P E Spencer; Manal M Abd-el-Mohsen; Catherine Rice-Evans
Journal:  Arch Biochem Biophys       Date:  2004-03-01       Impact factor: 4.013

View more
  6 in total

1.  Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin.

Authors:  Pamela Maher
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

2.  Improving the oral bioavailability of beneficial polyphenols through designed synergies.

Authors:  Arjan Scheepens; Kee Tan; James W Paxton
Journal:  Genes Nutr       Date:  2009-10-20       Impact factor: 5.523

3.  The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes.

Authors:  Bradley W Bolling; Michael H Court; Jeffrey B Blumberg; C-Y Oliver Chen
Journal:  J Nutr Biochem       Date:  2009-05-14       Impact factor: 6.048

Review 4.  How fisetin reduces the impact of age and disease on CNS function.

Authors:  Pamela Maher
Journal:  Front Biosci (Schol Ed)       Date:  2015-06-01

5.  Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells.

Authors:  Anna Klimaszewska-Wiśniewska; Dariusz Grzanka; Paulina Czajkowska; Marta Hałas-Wiśniewska; Justyna Durślewicz; Paulina Antosik; Alina Grzanka; Maciej Gagat
Journal:  Int J Oncol       Date:  2019-10-02       Impact factor: 5.650

Review 6.  The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis.

Authors:  Dimitra Kelepouri; Athanasios Mavropoulos; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  J Immunol Res       Date:  2018-03-05       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.